세계의 자동 세포 이미징 시스템 시장 규모, 점유율, 성장 분석 : 제품 및 서비스별, 용도별, 기술별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Automated Cell Imaging System Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Application (Drug Discovery, Diagnostics), By Technology, By End User, By Region - Industry Forecast 2025-2032
상품코드:1681640
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
자동 세포 이미징 시스템 2023년 시장 규모는 1,274억 8,000만 달러로 평가되었습니다. 또한, 2024년 1,379억 3,000만 달러에서 2032년에는 2,591억 1,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 8.2%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
자동 세포 이미징 시스템 시장은 전 세계 만성질환 유병률 증가와 의약품 및 백신 연구개발에 대한 투자 증가에 힘입어 강력한 성장이 예상됩니다. 그러나 높은 유지보수 비용과 예비 부품의 제한적인 가용성은 시장 확대에 걸림돌로 작용할 수 있습니다. 북미는 현재 첨단 헬스케어 기술의 조기 도입으로 시장을 독점하고 있으며, 미국이 이 분야에서 선두를 달리고 있습니다. 반면, 아시아태평양은 헬스케어 인프라에 대한 막대한 투자를 바탕으로 빠르게 성장하고 있습니다. 전반적으로 성장 기회는 유망하지만, 자동 세포 이미징 시스템 시장의 모멘텀을 지속하기 위해서는 기존 과제를 해결하는 것이 중요합니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 상황
자동 세포 이미징 시스템 시장 규모 : 제품 및 서비스별&CAGR(2025-2032년)
시장 개요
기기
소모품
소프트웨어
서비스
자동 세포 이미징 시스템 시장 규모 : 용도별&CAGR(2025-2032년)
시장 개요
Drug Discovery
진단
생물학 및 생물의학 조사
기타 용도
자동 세포 이미징 시스템 시장 규모 : 기술별&CAGR(2025-2032년)
시장 개요
형광 이미징
Brightfield Imaging
HCS(High Content Screening)
기타 기술
자동 세포 이미징 시스템 시장 규모 : 최종사용자별&CAGR(2025-2032년)
시장 개요
제약 기업 및 바이오테크놀러지 기업
학술연구기관
병원
진단 실험실
기타 최종사용자
자동 세포 이미징 시스템 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
General Electric Company(USA)
Olympus Corporation(Japan)
PerkinElmer Inc.(USA)
Sartorius AG(Germany)
Thermo Fisher Scientific Inc.(USA)
West Medica(Austria)
Norma Diagnostika GmbH(Germany)
BioView Ltd.(Israel)
Caliber I.D.(USA)
Molecular Devices, LLC(USA)
Nikon Corporation(Japan)
Leica Microsystems GmbH(Germany)
Carl Zeiss AG(Germany)
Agilent Technologies, Inc.(USA)
Becton, Dickinson and Company(USA)
Merck KGaA(Germany)
Tecan Group Ltd.(Switzerland)
Danaher Corporation(USA)
결론과 제안
LSH
영문 목차
영문목차
Automated Cell Imaging System Market size was valued at USD 127.48 billion in 2023 and is poised to grow from USD 137.93 billion in 2024 to USD 259.11 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).
The market for automated cell imaging systems is poised for robust growth, fueled by rising chronic disease prevalence globally and increased investment in drug and vaccine research and development. However, challenges such as high maintenance costs and limited spare parts availability may hinder market expansion. North America currently dominates the market, driven by early adoption of advanced healthcare technologies, with the USA leading in this sector. Meanwhile, the Asia-Pacific region is experiencing rapid growth, attributed to significant investments in healthcare infrastructure. Overall, while opportunities for growth are promising, addressing the existing challenges will be crucial to sustaining momentum in the automated cell imaging system market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Automated Cell Imaging System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Automated Cell Imaging System Market Segments Analysis
Global Automated Cell Imaging System Market is segmented by Product, Application, Technology, End User and region. Based on Product, the market is segmented into Instruments, Consumables, Software and Services. Based on Application, the market is segmented into Drug Discovery, Diagnostics, Biological and Biomedical Research and Other Applications. Based on Technology, the market is segmented into Fluorescence Imaging, Brightfield Imaging, High-Content Screening and Other Technologies. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Automated Cell Imaging System Market
The Automated Cell Imaging System market is significantly driven by the rising incidence of genetic deformities caused by lifestyle changes and radiation exposure, which can lead to irregular cell division and tumor development. Additionally, contamination of water, food, and soil with certain chemicals contributes to cancer prevalence. The emergence of new cancer types necessitates advanced imaging technologies to study the dynamics and functions of telomeric repeat-containing RNA, underscoring the importance of automated cell imaging systems. These systems have become essential tools in cellular research, enabling scientists to analyze digital microscopic images of cancerous cells with precision and efficiency, thereby propelling market growth.
Restraints in the Automated Cell Imaging System Market
The Automated Cell Imaging System market faces significant restraints due to the high costs associated with both spare parts and initial setup. When components of these systems become damaged, they often need to be fully replaced, leading to substantial expenses, exacerbated by the limited number of manufacturers available, which creates a supply deficit. Additionally, the initial investment necessary to establish such systems can be quite steep, coupled with the requirement for considerable electricity to operate them. These factors combined present notable challenges for market growth and limit accessibility for many potential users.
Market Trends of the Automated Cell Imaging System Market
The Automated Cell Imaging System market is witnessing significant growth driven by a surge in research and development of new drugs, as major pharmaceutical companies increasingly invest in advanced technologies. This trend is fueled by the need for high-throughput screening and precise analysis in drug discovery, as these systems minimize human error and reduce the time required for interventions in lengthy experiments involving extensive chemical libraries. By acquiring and analyzing high-resolution images, automated cell imaging systems enhance the efficiency and accuracy of research processes, thereby accelerating the development of innovative vaccines and therapeutics and positioning themselves as indispensable tools in modern biomedical research.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Global Automated Cell Imaging System Market Size by Product & Service & CAGR (2025-2032)
Market Overview
Instruments
Consumables
Software
Services
Global Automated Cell Imaging System Market Size by Application & CAGR (2025-2032)
Market Overview
Drug Discovery
Diagnostics
Biological and Biomedical Research
Other Applications
Global Automated Cell Imaging System Market Size by Technology & CAGR (2025-2032)
Market Overview
Fluorescence Imaging
Brightfield Imaging
High-Content Screening
Other Technologies
Global Automated Cell Imaging System Market Size by End User & CAGR (2025-2032)
Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals
Diagnostic Laboratories
Other End Users
Global Automated Cell Imaging System Market Size & CAGR (2025-2032)
North America (Product & Service, Application, Technology, End User)
US
Canada
Europe (Product & Service, Application, Technology, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product & Service, Application, Technology, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product & Service, Application, Technology, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product & Service, Application, Technology, End User)
